Eurocancer 1997

This publication presents an abridged synthesis of the most significant advances described by top specialists at the Eurocancer Days in June 7 1997.
- the field of common cancers (high-risk breast cancer, colonic-rectal cancer, small-cell bronchial cancer, upper aerodigestive voles cancer);
- the field of rarer cancers, in which very significant progress has been made
- the field of diagnostic and therapeutic procedures (imaging, positron emission tomography, intensive chemotherapy, pain management);
- sectors in which research advances have been the most striking, especially pharmacology for predicting chemosensitivity, oncogenetics, cancerlological immunology and gene therapy.